Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is
Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is

Cynvenio Liquid Biop Automated Rare Cell Platform CLEARANCE! As-Is

sku: 3345967
1 In Stock
Condition : Pre-owned
Warranty : AS-IS
Region : US
$4,349.00$14,500.00
Apply For Finance
Make Offer
Enquiry Here
ADD TO CART
  • Make Cynvenio
  • Hertz 50Hz/60Hz
  • Model LiquidBiopsy Platform v1.2
  • Serial CB 034-141130
  • Weight 400
  • Voltage 120V/220V
  • Working Working
  • Includes Power Cord
  • Warranty AS-IS
  • Dimensions 32×39×45 in
  • Shipping Type Freight
  • Item Condition Pre-owned

The LiquidBiopsy Platform simplifies the isolation, enumeration, and molecular analysis of rare cells and cell-free DNA (cfDNA) from whole-blood samples. Achieving high target cell recovery and exceptional purity, the platform enables downstream molecular characterization of rare cells using next-generation sequencing (NGS), FISH and IHC.

The LiquidBiopsy Platform is part of a comprehensive, cost-effective workflow for the automated isolation, enumeration, and analysis of rare cells. High CTC capture rates are critical in patient monitoring applications because thereare usually less than 10 CTCs in a 7.5 mL whole blood sample (1 target cell per billion).

Sample multiplexing and a one-day blood drawto-sequence workflow accelerate turnaround time for higher- throughput laboratories.

The proprietary Cynvenio sheath flow chip uniquely supports patient monitoring applications. It achieves high purity while capturing CTCs using immunomagnetic positive selection. This flow chip enables low-input DNA sequencing without the need for whole-genome amplification. The chip can then be used to stain and scan the captured target cells.

Manufacture Specifications

  • Optimized LiquidBiopsy worflow
  • Up to a 48 hour turn-around
  • Variant detection: 0.1% to 1% sensitivity
  • CTC enrichment: 1 in a billion cells
  • Detects somatic & germline mutations

The flexible design of the LiquidBiopsy platform supports a variety of research areas, including:

  • Oncology
  • Endothelial Cells
  • Stem Cell Research
  • Fetal Cells / Noninvasive Prenatal Testing (NiPT)
  • Immunology
  • Peptide/Aptamer Libraries
  • Infectious Disease

Testimonials

★★★★★

“REUZEit has been a great partner for our used equipment needs and always provide timely updates of new arrivals of consigned equipment.”

★★★★★

“Great company to work with. Tammy completed our first international equipment shipment with ease.”

★★★★★

“Fast response, open to adjusting schedule as needed, and great customer interaction.”